GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Guangzhou Kingmed Diagnostics Group Co., Ltd. Stock
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.1 CNY | -9.61% |
|
-14.21% | -39.11% |
| Sales 2024 * | 10.26B 1.42B | Sales 2025 * | 12.22B 1.69B | Capitalization | 17.86B 2.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.15B 159M | Net income 2025 * | 1.5B 208M | EV / Sales 2024 * | 1.13 x |
| Net cash position 2024 * | 6.31B 870M | Net cash position 2025 * | 7.24B 1B | EV / Sales 2025 * | 0.87 x |
| P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
11.6
x | Employees | 14,411 |
| Yield 2024 * |
1.69% | Yield 2025 * |
2.2% | Free-Float | 58.12% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -9.61% | ||
| 1 week | -14.21% | ||
| Current month | -32.28% | ||
| 1 month | -32.78% | ||
| 3 months | -30.82% | ||
| 6 months | -29.14% | ||
| Current year | -39.11% |
1 week
37.95
45.74
1 month
37.9557.59
Current year
37.9566.87
1 year
37.9583.50
3 years
37.95160.19
5 years
29.20178.88
10 years
9.98178.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Bi Xi Hao
DFI | Director of Finance/CFO | 54 | 10-12-31 |
Xiao Feng Zou
BRD | Director/Board Member | 44 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jing Ming Xu
BRD | Director/Board Member | 52 | 17-04-17 |
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Yu Miao Yu
BRD | Director/Board Member | 59 | 17-06-23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.63% | 2 M€ | -16.59% | - | |
| 0.41% | 2 M€ | -14.14% | ||
| 0.37% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 38.1 | -9.61% | 18,012,810 |
| 24-04-25 | 42.15 | -0.94% | 4,409,400 |
| 24-04-24 | 42.55 | -3.95% | 4,995,300 |
| 24-04-23 | 44.3 | -1.23% | 5,728,201 |
| 24-04-22 | 44.85 | +0.99% | 3,295,658 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
38.1
CNY
Average target price
77.09
CNY
Spread / Average Target
+102.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.11% | 2.73B | |
| -17.89% | 8.36B | |
| +39.20% | 3.6B | |
| -8.06% | 2.47B | |
| -7.35% | 2.32B | |
| -12.61% | 1.77B | |
| -19.01% | 1.55B | |
| -40.66% | 1.22B | |
| +7.56% | 1.09B | |
| -15.34% | 1.03B |
- Stock Market
- Equities
- 603882 Stock
